What are reversible inhibitors of monoamine oxidase A?
•
4 min read
Monoamine oxidase inhibitors (MAOIs) were among the first antidepressants developed, but their use was limited by severe dietary interactions that could lead to dangerous hypertensive crises. The development of **reversible inhibitors of monoamine oxidase A** (RIMAs) marked a significant advance in pharmacology, creating a safer alternative for patients requiring this therapeutic class.
